Document:

EX-4.2.2

 

Exhibit 4.2.2

CARDINAL HEALTH, INC.

Officers’ Certificate 

     Pursuant to Sections 2.3 and 2.4 of the Indenture dated as of
April 18, 1997 (the “Indenture”) between Cardinal Health, Inc. (the
“Company”) and Bank One. NA (formerly known as Bank One, Columbus,
NA), as Trustee (the “Trustee”), the undersigned officers of the
Company do hereby certify as follows in connection with the issuance
of the Company’s 6.25% Notes Due 2008 (the “Securities”) under the
Indenture:

     1. All conditions precedent under the Indenture to the issuance and
authentication of the Securities and the delivery of the Securities
to the Company have been complied with.

     2. The undersigned have read the conditions referred to in paragraph 1 above.

     3. The statements of the undersigned contained herein are based
upon their participation in the issuance of the Securities and a
review of the Indenture.

     4. Each of the undersigned has made such examination or
investigation as is necessary in the undersigned’s opinion to enable the undersigned to
express an informed opinion as to whether the conditions referred to in
paragraph I above have been complied with.

 

 

     5. The terms of the 6.25°’ Notes are as follows:

Title: 6.25% Notes Due 2008

Limit of aggregate

principal amount: U.S.$150,000,000

Maturity Date: July 15, 2008

Interest: 6.25% per annum

Dated: July 13, 1998

	 	 	 	 	 
	 	CARDINAL HEALTH, INC.

 	 
	 	By /s/ Stephanie A. Wagoner	 
	 	 
	 
	 	Name:  	Stephanie A. Wagoner 	 
	 	Title:  	Vice President and

Treasurer 	 
	 
	 	 	 
	 	                                       By             /s/ George H. Bennett, Jr.
 	 
	 	 
	 
	 	Name:  	George H. Bennett, Jr. 	 
	 	Title:  	Executive Vice President,

General Counsel and Secretary 	 
	 

2EX-4.2.3

 

Exhibit 4.2.3

CARDINAL HEALTH, INC.

Officer’s Certificate

     Pursuant to Section 2.3 and 2.4 of the Indenture dated as of April 18, 1997
(the “Indenture”) between Cardinal Health, Inc. (the “Company”) and Bank One, N.A.
(formerly known as Bank One, Columbus, N.A.), as Trustee (the “Trustee”), the undersigned
officers of the Company do hereby certify as follows in connection with the
issuance of the Company’s 6.75% Notes due 2011 (the “Securities”) under the Indenture:

          1. All conditions precedent under the Indenture to the issuance and
authentication of the Securities and the delivery of the Securities to the Company have
been complied with.

          2. The undersigned have read the conditions referred to in paragraph 1 above.

          3. The statements of the undersigned contained herein are based upon their participation in
the issuance of the Securities and a review of the Indenture.

          4. Each of the undersigned has made such examination or investigation as is necessary in the
undersigned’s opinion to enable the undersigned to express an informed opinion as to whether the conditions referred to in paragraph 1 above have been complied
with.

          5. The terms of the Securities are as follows:

     Title: 6.75% Notes due 2011

          Limit of aggregate principal amount: U.S. $500,000,000

     Maturity Date February 15, 2011

     Interest: 6.75% per annum

 

 

	 	 	 	 	 
	 

	 	Optional Redemption Provisions:
	 	The Notes will be redeemable, in whole or, from
time to time, in part, at the option of the
Company at any time, at a redemption price
equal to the greater of: (i) 100% of the principal
amount of the Notes to be redeemed, or (ii) as
determined by a Quotation Agent, the sum of
the present values of the remaining scheduled payments of
principal and interest thereon (exclusive of interest
accrued to the date of redemption) discounted to the date
of redemption on a semiannual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Adjusted
Treasury Rate plus 15 basis points, plus, in each case,
accrued and unpaid interest on the principal amount being
redeemed to the date of redemption.

	 	 	 	 	 
	 

	 	Interest Payment Dates:
	 	February 15 and August 15, commencing August 15,
2001

	 	 	 	 	 
	 

	 Interest Accrues From:
	 	February 13, 2001

Dated: February 13, 2001

	 	 	 	 	 
	 	CARDINAL HEALTH, INC.

 	 
	 	/s/ Richard J. Miller
 	 
	 	Name:  	Richard J. Miller 	 
	 	Title:  	Executive Vice President and

     Chief Financial Officer 	 
	 
	 	 	 
	 	                                   /s/ Donna Brandin
 	 
	 	Name:  	Donna Brandin 	 
	 	Title:  	Senior Vice President and

TreasurerEX-4.2.4

 

Exhibit 4.2.4

CARDINAL HEALTH, INC.

Officer’s Certificate

     Pursuant to Section 2.3 and 2.4 of the Indenture dated as of April 18, 1997 (the
“Indenture”) between Cardinal Health, Inc. (the “Company”) and Bank One, N.A.
(formerly known as Bank One, Columbus, N.A.), as Trustee (the “Trustee”), the undersigned
officers of the Company do hereby certify as follows in connection with the issuance of the
Company’s 4.00% Notes due 2015 (the “Securities”) under the Indenture:

          1. All conditions precedent under the Indenture to the issuance and
authentication of the Securities and the delivery of the Securities to the Company have
been complied with.

          2. The undersigned have read the conditions referred to in paragraph 1
above.

          3. The statements of the undersigned contained herein are based upon their
participation in the issuance of the Securities and a review of the Indenture.

          4. Each of the undersigned has made such examination or investigation as is necessary in the
undersigned’s opinion to enable the undersigned to express an informed opinion as to whether the
conditions referred to in paragraph 1 above have been complied with.

          5. The terms of the Securities are as follows:

               Title: 4.00% Notes due 2015

               Limit of aggregate principal amount: U.S. $500,000,000

               Maturity Date: June 15, 2015

               Interest: 4.00% per annum

	 	 	 	 	 
	 

	 Interest Payment
	 	December 15 and June 15, commencing
	 

	 Dates:
	 	December 15, 2003

 

 

	 	 	 	 	 
	 

	 	Record Dates:
	 	June 1 and December 1
	 
	 	 	 	 
	 

	 	   Interest Accrues

   From:
	 	June 17, 2003
	 
	 	 	 	 
	 

	 	   Optional Redemption:
	 	The Notes will be redeemable, in whole or, from
time to time, in part, at the option of the Company at any
time, at a redemption price equal to the greater of:
	 
	 	 	 	 
	 

	 	 	 	(1) 100% of the principal amount of the Notes to be
redeemed, or
	 
	 	 	 	 
	 

	 	 	 	(2) as determined by a Quotation Agent, the sum of the
present values of the remaining scheduled payments of
principal and interest thereon (exclusive of interest
accrued to the date of redemption) discounted to the date
of redemption on a semiannual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Adjusted
Treasury Rate plus 15 basis points,
	 
	 	 	 	 
	 

	 	 	 	plus, in each case, accrued and unpaid
interest on the amount being redeemed to
the date of redemption.

          Each capitalized term used but not defined herein shall have the meaning
assigned thereto in the Indenture or the Note.

 

 

Dated: June 17, 2003

	 	 	 	 	 
	 	CARDINAL HEALTH, INC.

 	 
	 	/s/ Richard J. Miller
 	 
	 	Name:  	Richard J. Miller 	 
	 	Title:  	Executive Vice President and

     Chief Financial Officer 	 
	 
	 	 	 
	 	     /s/ Donna Brandin
 	 
	 	Name:  	Donna Brandin 	 
	 	Title:  	Senior Vice President and

TreasurerEX-4.2.5

 

EXHIBIT 4.2.5

CARDINAL HEALTH, INC.

OFFICERS’ CERTIFICATE

          Pursuant to Section 2.3 and 2.4 of the Indenture dated as of April 18, 1997 (the
“Indenture”) between Cardinal Health, Inc. (the “Company”) and J.P. Morgan Trust
Company, National Association (successor to Bank One, N.A., formerly known as Bank One, Columbus,
N.A.), as Trustee (the “Trustee”), the undersigned officers of the Company do hereby
certify as follows in connection with the issuance of the Company’s 5.85% Notes due 2017 (the
“Securities”) under the Indenture:

          1. All conditions precedent under the Indenture to the issuance and authentication of the
Securities and the delivery of the Securities to the Company have been complied with.

          2. The undersigned have read the conditions referred to in paragraph 1 above.

          3. The statements of the undersigned contained herein are based upon their participation in
the issuance of the Securities and a review of the Indenture.

          4. Each of the undersigned has made such examination or investigation as is necessary in the
undersigned’s opinion to enable the undersigned to express an informed opinion as to whether the
conditions referred to in paragraph 1 above have been complied with.

          5. The terms of the Securities are as follows:

              Title: 5.85% Notes due 2017

              Initial aggregate principal amount: U.S. $500,000,000

              Maturity Date: December 15, 2017

              Interest: 5.85% per annum

	 	 	 	 	 
	 

	 	Interest Payment
	 	June 15 and December 15, commencing
	 

	 	Dates:
	 	June 15, 2006
	 
	 	 	 	 
	 

	 	Record Dates:
	 	June 1 and December 1
	 
	 	 	 	 
	 

	 	Interest Accrues
	 	December 15, 2005
	 

	 	From:	 	 

 

 

	 	 	 	 	 
	 

	 	Optional Redemption:
	 	The Notes will be redeemable, in whole
or, from time to time, in part, at the option of the
Company at any time, at a redemption price equal to the
greater of:
	 
	 	 	 	 
	 

	 	 	 	(1) 100% of the principal amount of
the Notes to be redeemed, or
	 
	 	 	 	 
	 

	 	 	 	(2) as determined by a Quotation
Agent, the sum of the present
values of the remaining scheduled
payments of principal and interest
thereon (exclusive of interest
accrued to the date of redemption)
discounted to the date of
redemption on a semiannual basis
(assuming a 360-day year consisting
of twelve 30-day months) at the
Adjusted Treasury Rate plus 20
basis points,
	 
	 	 	 	 
	 

	 	 	 	plus, in each case, accrued and
unpaid interest on the amount
being redeemed to the date of
redemption.

          Each capitalized term used but not defined herein shall have the meaning assigned thereto in
the Indenture or the Note.

2

 

Dated: December 15, 2005

	 	 	 	 	 
	 	CARDINAL HEALTH, INC.

 	 
	 	/s/ Jeffrey W. Henderson
 	 
	 	Name:  	Jeffrey W. Henderson 	 
	 	Title:  	Executive Vice President and

Chief Financial Officer 	 
	 
	 	 	 
	 	                    /s/ Linda S. Harty
 	 
	 	Name:  	Linda S. Harty 	 
	 	Title:  	Senior Vice President and

Treasurer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]